RNU6-1206P

Across TCGA pan-cancer cohorts, RNU6-1206P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-1206P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU6-1206P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1206P expression acts as an unfavorable survival marker, although some lineages such as LUSC and MESO show a favorable association.

UVM, LIHC, and PCPG are the cancer types where RNU6-1206P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	III,IV	0.211	0.724	<.001	69	view →
LIHC	OS	Tertile	All	0.566	0.725	.006	33	view →
PCPG	OS	Tertile	All	0.890	0.992	.001	21	view →
LUSC	DFS	Tertile	III,IV	0.685	0.407	.013	16	view →
SKCM	DFS	Tertile	III,IV	0.479	0.675	.025	15	view →
MESO	OS	Median	II,III,IV	0.717	0.485	.029	10	view →
THCA	DFS	Median	IV	0.578	0.931	.033	8	view →
BLCA	OS	Tertile	IV	0.435	0.214	.047	5	view →
CHOL	DFS	Median	II,III,IV	0.107	0.580	.019	3	view →
THYM	DFS	Median	All	0.834	0.984	.029	3	view →
ESCA	OS	Median	II,III,IV	0.617	1.000	.049	3	view →
DLBC	DFS	Tertile	II,III,IV	0.548	0.881	.049	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-1206P–UVM (OS)

Open the UVM breakdown →